Category: Pharma Industry

Transparency, Patient Assistance Requirements Needed in 340B, Say Drugmaker-Backed Groups

September 28, 2023 Rich Daly, Editor in Chief Views

Justin Leventhal, a senior policy analyst for the American Consumer Institute, has advocated for more 340B transparency alongside other drugmaker-backed groups.

Amid ongoing congressional legislative proposals to boost transparency and other requirements for 340B hospitals, two advocacy groups that receive drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Try a Range of Responses to Manufacturer 340B Contract Pharmacy Restrictions

September 26, 2023 Rich Daly, Editor in Chief Views

Community health centers are attempting to mitigate the adverse financial effects of manufacturer 340B contract pharmacy restrictions on their organizations, said Colleen Meiman, national policy advisor for State & Regional Associations of Community Health Centers.

Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Judges Press Both Sides in Key Hearing on Arkansas 340B Contract Pharmacy Law

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

Chief Judge Lavenski Smith of the 8th Circuit Court of Appeals and two other federal judges heard highly anticipated oral arguments for PhRMA v. McClain in a case that challenges Arkansas' 340B contract pharmacy law.

Attorneys representing Arkansas and 340B providers sparred with a drug industry lawyer over the constitutionality of Arkansas’ first-in-the-nation 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Teva Ends 340B Contract Pharmacy Restrictions in Arkansas in Response to State Law

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

The final HRSA manufacturer 340B program audit conducted in fiscal year 2023 had no adverse findings for Teva Pharmaceuticals.

Teva Pharmaceuticals this week ended its 340B contract pharmacy restrictions in Arkansas in response to a state law that prevents [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Incyte Becomes 26th Drugmaker to Place Contract Pharmacy Restrictions

September 21, 2023 Rich Daly, Editor in Chief Views

Incyte will no longer allow 340B hospitals to have direct delivery of Opzelura products purchased at the 340B discount price to contract pharmacies.

Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk Providing 340B Refunds on Blockbuster Drug Ozempic

September 19, 2023 Tom Mirga, Editor at Large Views

Drugmaker Novo Nordisk is issuing 340B refunds for certain purchases of its blockbuster diabetes medication Ozempic.

Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana AG Defends State 340B Contract Pharmacy Law Against Drug Industry Lawsuit

September 14, 2023 William Newton, Associate Editor/Senior Writer Views

Four hospital associations filed an amicus brief in support of Louisiana Attorney General Jeff Landry's defense of his state's contract pharmacy law.

The Louisiana attorney general recently asked a federal district judge to dismiss a drug industry lawsuit that challenges Louisiana’s 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two More Drugmakers Owe 340B Provider Repayments, HRSA Audits Find

September 14, 2023 Rich Daly, Editor in Chief Views

The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.

Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Jazz Pharmaceuticals Is 25th Drugmaker to Implement Contract Pharmacy Restrictions

September 12, 2023 Rich Daly, Editor in Chief Views

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.

Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sanofi Withdraws Some Health Centers’ 340B Pricing at Contract Pharmacies

September 12, 2023 Tom Mirga, Editor at Large Views

Sanofi has recently denied some health centers access to 340B pricing at contract pharmacies after saying they did not conform to Sanofi's policy.

Drug manufacturer Sanofi recently started denying access for some health centers to 340B pricing at contract pharmacies after previously saying [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live